In this study, we included all patients admitted to the Emergency Department “St. Spiridon” Iasi for voluntary/accidental exposure to cannabis, synthetic cannabinoids and new psychoactive (ethnobotanical) substances. We used the data recorded in the clinical observation files. The inclusion criteria were: aged over 18 years, anamnestic data, clinical examination and specific symptomatology to exposure to the above-mentioned drugs and patients with toxicological and laboratory determinations suggestive for the diagnosis of cannabis, synthetic cannabinoids and new psychoactive intoxication (ethnobotanical).
Patients with incomplete data recorded in the clinical observation files were excluded from the study. Additionally, those patients whose index perfusion tissue could not be determined upon admission to the emergency department or who were initially consulted in another health unit and later directed to St. Spiridon Hospital Iasi were excluded from the study.
Other exclusion criteria were: history of vascular diseases (diabetes, hypertension), patients with circulatory failure associated with hypovolemia and low cardiac output.
A urine drug screening test using an immunoassay (Triage Meter Pro) was used to screen for amphetamines, barbiturates, benzodiazepines, cocaine, methadone, methamphetamines (including MDMA), opiates, phencyclidine (PCP), tricyclic antidepressants and tetrahydrocannabinol (cannabis).
Free full text:
Click here
Grigorasi G.R., Corlade-Andrei M., Ciumanghel I., Sova I., Blaga T., Carp C, & Cimpoesu D. (2023). Monitoring Perfusion Index in Patients Presenting to the Emergency Department Due to Drug Use. Journal of Personalized Medicine, 13(2), 372.